Archive

The Patient Engagement Gap Your Competitors Are Closing

February 27, 2026

Here’s a question more pharma executives are asking: does patient engagement deliver measurable value, or is it primarily reputational?  It’s a fair question.  In an era where pharmaceutical innovation must demonstrate its value not only through clinical efficacy but also through demonstrated patient relevance, the question is no longer ‘whether’ to engage patients – it’s whether that engagement translates into an advantage.  New research from FleishmanHillard’s Global Health & Life Sciences group suggests it may. Released in recognition of Rare Disease Day, The Patient Engagement Premium: Defining the Strategic Value...